The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations.

[1]  J. A. Bishop,et al.  A mutation hotspot at the p14ARF splice site , 2005, Oncogene.

[2]  J. Kładny,et al.  CDKN2A common variants and their association with melanoma risk: a population-based study. , 2005, Cancer research.

[3]  E. Bar-Meir,et al.  Genetics in melanoma. , 2004, The Israel Medical Association journal : IMAJ.

[4]  J. Barrett,et al.  An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. , 2002, The Journal of investigative dermatology.

[5]  A. Howell,et al.  Germline mutation of ARF in a melanoma kindred. , 2002, Human molecular genetics.

[6]  K. Hemminki,et al.  A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare , 2001, International journal of cancer.

[7]  D. Bishop,et al.  Mutation screening of the CDKN2A promoter in melanoma families , 2000, Genes, chromosomes & cancer.

[8]  P. Bruzzi,et al.  Characterization of ligurian melanoma families and risk of occurrence of other neoplasia , 1999, International journal of cancer.

[9]  D. Duffy,et al.  CDKN2A variants in a population-based sample of Queensland families with melanoma. , 1999, Journal of the National Cancer Institute.

[10]  D. Stoppa-Lyonnet,et al.  Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. , 1998, Human molecular genetics.

[11]  K. Isselbacher,et al.  Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Sutherland,et al.  Cancer‐associated mis‐sense and deletion mutations impair p16INK4 CDK inhibitory activity , 1996, International journal of cancer.

[13]  B. Peters,et al.  Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. , 1995, Oncogene.

[14]  N. Hayward,et al.  Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. , 1995, Human molecular genetics.

[15]  H. Varmus,et al.  Mutations associated with familial melanoma impair p16INK4 function , 1995, Nature Genetics.

[16]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[17]  M. Skolnick,et al.  Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.